Abstract The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, β-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used β-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism.
AbstractList The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, β-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used β-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism.
The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, [beta]-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used [beta]-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism. Diabetes 2014;63:1203-1213 | DOI: 10.2337/db13-1198
The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, β-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used β-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism.The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, β-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used β-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism.
The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and diabetic humans. We review the oral minimal method (i.e., models that allow the estimation of insulin sensitivity, β-cell responsivity, and hepatic insulin extraction from a mixed-meal or an oral glucose tolerance test). Both of these oral tests are more physiologic and simpler to administer than those based on an intravenous test (e.g., a glucose clamp or an intravenous glucose tolerance test). The focus of this review is on indices provided by physiological-based models and their validation against the glucose clamp technique. We discuss first the oral minimal model method rationale, data, and protocols. Then we present the three minimal models and the indices they provide. The disposition index paradigm, a widely used β-cell function metric, is revisited in the context of individual versus population modeling. Adding a glucose tracer to the oral dose significantly enhances the assessment of insulin action by segregating insulin sensitivity into its glucose disposal and hepatic components. The oral minimal model method, by quantitatively portraying the complex relationships between the major players of glucose metabolism, is able to provide novel insights regarding the regulation of postprandial metabolism. Diabetes 2014;63:1203-1213 | DOI: 10.2337/db13-1198
Audience Professional
Author Dalla Man, Chiara
Vella, Adrian
Toffolo, Gianna
Rizza, Robert
Basu, Rita
Cobelli, Claudio
Author_xml – sequence: 1
  givenname: Claudio
  surname: Cobelli
  fullname: Cobelli, Claudio
  organization: Department of Information Engineering, University of Padova, Padova, Italy
– sequence: 2
  givenname: Chiara
  surname: Dalla Man
  fullname: Dalla Man, Chiara
  organization: Department of Information Engineering, University of Padova, Padova, Italy
– sequence: 3
  givenname: Gianna
  surname: Toffolo
  fullname: Toffolo, Gianna
  organization: Department of Information Engineering, University of Padova, Padova, Italy
– sequence: 4
  givenname: Rita
  surname: Basu
  fullname: Basu, Rita
  organization: Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN
– sequence: 5
  givenname: Adrian
  surname: Vella
  fullname: Vella, Adrian
  organization: Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN
– sequence: 6
  givenname: Robert
  surname: Rizza
  fullname: Rizza, Robert
  organization: Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=28402928$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/24651807$$D View this record in MEDLINE/PubMed
BookMark eNp9klFrFDEQx4NU7LX64AdQCiLow7aZzSa7-1Ioh1bh5F5a6FvIJpO9lL2kbnZFv71Zeu159iiBBJLf_Oc_mTkiBz54JOQt0NOcsfLMNMAygLp6QWZQszpjeXlzQGaUQp5BWZeH5CjGW0qpSOsVOcwLwaGi5Yy8u1rhybJX3ckP5916OoPBtOOwCuY1eWlVF_HN5jwm11-_XM2_ZYvl5ff5xSLTohRDVtScWs4sMlVZwUojSqxy2ggKvDbcoGkEAGfUaE0NaqVt05QmN0Jxy5hhx-T8XvdubNZoNPohWZJ3fXLU_5FBObn74t1KtuGXLFJ1DFgS-LQR6MPPEeMg1y5q7DrlMYxRAqd1AQCsTuiH_9DbMPY-lScheRcFZRS2VKs6lM7bkPLqSVReMMGgqngxpc32UC16TCZTj6xL1zv86R4-LYNrp_cGfN4JSMyAv4dWjTHK6nLxnJkNq0PXYYsyNWy-3OXf__vpj7_9MBwJ-LgBVNSqs73y2sUtVxU0r_MqcWf3nO5DjD1aqd2gBhemXrlOApXTmMppTOU0ptuyHiMeRJ-yfwEduOC0
CODEN DIAEAZ
CitedBy_id crossref_primary_10_3389_fendo_2021_611253
crossref_primary_10_1038_s41598_019_45858_w
crossref_primary_10_2337_db17_0188
crossref_primary_10_1152_japplphysiol_00212_2017
crossref_primary_10_1111_dom_13106
crossref_primary_10_1152_ajpendo_00070_2021
crossref_primary_10_1210_clinem_dgz207
crossref_primary_10_1136_bmjopen_2021_060668
crossref_primary_10_1113_JP284061
crossref_primary_10_1210_clinem_dgae545
crossref_primary_10_3389_fphar_2015_00258
crossref_primary_10_3945_jn_114_202010
crossref_primary_10_1007_s00125_022_05794_3
crossref_primary_10_3389_fphys_2022_911616
crossref_primary_10_1111_dom_14394
crossref_primary_10_1007_s40435_018_0445_8
crossref_primary_10_1002_ppul_26533
crossref_primary_10_1016_j_cmpb_2020_105911
crossref_primary_10_2337_db16_0569
crossref_primary_10_2337_dbi16_0049
crossref_primary_10_3389_fendo_2021_694390
crossref_primary_10_2337_dc17_0290
crossref_primary_10_1042_CS20230586
crossref_primary_10_1139_apnm_2018_0802
crossref_primary_10_1016_j_conctc_2018_03_009
crossref_primary_10_1152_ajpendo_00519_2018
crossref_primary_10_1210_jendso_bvae130
crossref_primary_10_3389_fphys_2020_575789
crossref_primary_10_1371_journal_pone_0212738
crossref_primary_10_2337_db22_0746
crossref_primary_10_1016_j_jtbi_2016_12_018
crossref_primary_10_1016_j_rceng_2019_12_004
crossref_primary_10_1152_ajpendo_00316_2017
crossref_primary_10_1016_j_xcrm_2024_101682
crossref_primary_10_1016_j_physbeh_2020_113071
crossref_primary_10_1111_pedi_12816
crossref_primary_10_3390_toxics8020030
crossref_primary_10_1007_s00125_017_4317_0
crossref_primary_10_1172_jci_insight_165709
crossref_primary_10_1089_met_2018_0022
crossref_primary_10_1152_ajpendo_00199_2014
crossref_primary_10_3389_fendo_2019_00554
crossref_primary_10_1016_j_metop_2021_100078
crossref_primary_10_1152_ajpendo_00278_2023
crossref_primary_10_1177_19322968211015268
crossref_primary_10_1152_ajpendo_00133_2019
crossref_primary_10_1016_j_metabol_2021_154776
crossref_primary_10_1007_s00125_023_06011_5
crossref_primary_10_1016_j_jmb_2019_12_038
crossref_primary_10_1016_j_metabol_2016_03_002
crossref_primary_10_14814_phy2_13106
crossref_primary_10_1089_met_2018_0024
crossref_primary_10_1177_0748730417693480
crossref_primary_10_1016_j_metabol_2018_12_005
crossref_primary_10_1007_s00125_024_06323_0
crossref_primary_10_2337_db14_1701
crossref_primary_10_2337_db24_0163
crossref_primary_10_1017_S0029665119001034
crossref_primary_10_1210_jc_2016_1998
crossref_primary_10_1152_ajpendo_00350_2014
crossref_primary_10_1109_JBHI_2018_2811706
crossref_primary_10_1007_s10928_020_09726_9
crossref_primary_10_2337_db15_1233
crossref_primary_10_2337_db23_0613
crossref_primary_10_1089_dia_2015_0333
crossref_primary_10_3389_fendo_2024_1394190
crossref_primary_10_1109_ACCESS_2023_3259425
crossref_primary_10_1111_pedi_13072
crossref_primary_10_1089_dia_2016_0148
crossref_primary_10_1152_ajpendo_00284_2021
crossref_primary_10_4093_dmj_2016_40_4_308
crossref_primary_10_1002_oby_23317
crossref_primary_10_1177_19322968231206798
crossref_primary_10_2337_dc19_2432
crossref_primary_10_1210_clinem_dgaf086
crossref_primary_10_33590_emjdiabet_10313184
crossref_primary_10_3389_fendo_2024_1376530
crossref_primary_10_1152_ajpendo_00512_2019
crossref_primary_10_1210_clinem_dgac446
crossref_primary_10_2337_dc15_2035
crossref_primary_10_1016_j_soard_2022_10_037
crossref_primary_10_1210_jc_2017_01197
crossref_primary_10_1152_physiol_00009_2016
crossref_primary_10_1007_s12020_020_02576_y
crossref_primary_10_1152_ajpendo_00189_2023
crossref_primary_10_3389_fphar_2023_1088670
crossref_primary_10_1177_1932296819851135
crossref_primary_10_2337_db14_0513
crossref_primary_10_1016_j_bspc_2016_06_007
crossref_primary_10_1210_jc_2019_00161
crossref_primary_10_1016_j_appet_2021_105292
crossref_primary_10_1155_2023_7127426
crossref_primary_10_1007_s11892_018_1023_3
crossref_primary_10_1371_journal_pcbi_1012198
crossref_primary_10_3390_metabo11070409
crossref_primary_10_1038_srep36029
crossref_primary_10_1089_thy_2015_0005
crossref_primary_10_1111_dom_14646
crossref_primary_10_3389_fendo_2024_1340346
crossref_primary_10_1152_ajpendo_00488_2020
crossref_primary_10_1186_s12917_022_03394_2
crossref_primary_10_1111_eci_13469
crossref_primary_10_1152_ajpendo_00294_2023
crossref_primary_10_1186_s12933_018_0738_4
crossref_primary_10_1137_22M1506225
crossref_primary_10_1152_ajpendo_00527_2015
crossref_primary_10_1210_clinem_dgae572
crossref_primary_10_2337_dc24_1280
crossref_primary_10_3390_s19245386
crossref_primary_10_1152_ajpendo_00362_2015
crossref_primary_10_1210_jendso_bvaf020
crossref_primary_10_2337_dc15_0931
crossref_primary_10_2337_db22_0709
crossref_primary_10_1210_clinem_dgab344
crossref_primary_10_1007_s00125_016_4143_9
crossref_primary_10_1016_j_celrep_2018_06_039
crossref_primary_10_1016_j_jdiacomp_2020_107589
crossref_primary_10_1111_dom_13391
crossref_primary_10_1210_js_2018_00222
crossref_primary_10_1111_dom_13527
crossref_primary_10_1109_ACCESS_2021_3100007
crossref_primary_10_2337_dc17_1373
crossref_primary_10_1038_s41540_018_0051_6
crossref_primary_10_1208_s12248_015_9808_7
crossref_primary_10_1016_j_bbalip_2014_12_002
crossref_primary_10_2337_dc19_1675
crossref_primary_10_1038_s41380_018_0045_1
crossref_primary_10_5665_sleep_6028
crossref_primary_10_1210_clinem_dgac740
crossref_primary_10_1049_iet_syb_2017_0093
crossref_primary_10_1177_1932296819880864
crossref_primary_10_2337_dc20_0445
crossref_primary_10_1111_dom_13005
crossref_primary_10_1371_journal_pcbi_1006145
crossref_primary_10_1016_j_metabol_2020_154175
crossref_primary_10_2337_dc22_0338
crossref_primary_10_1016_j_mayocp_2015_01_019
crossref_primary_10_1089_met_2017_0130
crossref_primary_10_1210_clinem_dgad392
crossref_primary_10_1016_j_ajcnut_2023_07_018
crossref_primary_10_1089_met_2021_0136
crossref_primary_10_1111_dom_13939
crossref_primary_10_1155_2019_7891359
crossref_primary_10_1249_MSS_0000000000000728
crossref_primary_10_1007_s00125_018_4553_y
crossref_primary_10_1038_s41366_023_01257_w
crossref_primary_10_1109_TBME_2021_3101589
crossref_primary_10_1152_ajpendo_00043_2023
crossref_primary_10_1172_jci_insight_136136
crossref_primary_10_3389_fphys_2022_923704
crossref_primary_10_1016_j_metabol_2014_05_012
crossref_primary_10_1210_clinem_dgae915
crossref_primary_10_1111_nmo_13724
crossref_primary_10_1152_ajpendo_00358_2014
crossref_primary_10_1089_dia_2017_0397
crossref_primary_10_2337_db24_0192
crossref_primary_10_1007_s40261_015_0331_5
crossref_primary_10_1016_j_rce_2019_12_003
crossref_primary_10_1016_j_celrep_2016_04_024
crossref_primary_10_3389_fphys_2022_895118
crossref_primary_10_3390_ijms23031221
crossref_primary_10_1152_ajpregu_00369_2016
Cites_doi 10.2337/db06-1272
10.1152/ajpendo.00705.2009
10.1152/ajpendo.00486.2007
10.1152/ajpendo.00319.2003
10.2337/db12-0923
10.2337/db05-1692
10.1152/ajpendo.00033.2006
10.1152/ajpendo.00139.2011
10.2337/diabetes.53.5.1201
10.1152/ajpendo.00299.2004
10.1038/oby.2010.44
10.1172/JCI110398
10.2337/db11-1478
10.2337/db12-1759
10.1055/s-0033-1337988
10.1109/10.995680
10.1038/oby.2008.496
10.2337/db06-1776
10.1152/ajpendo.00473.2004
10.1111/j.1365-2265.2009.03764.x
10.2337/db11-1677
10.1152/ajpendo.00421.2006
10.1152/ajpendo.00093.2002
10.2337/dc08-1826
10.1152/ajpendo.90340.2008
10.2337/diabetes.50.1.150
10.2337/diabetes.41.3.368
10.1152/ajpendo.00670.2009
10.2337/dc08-1274
10.2337/dc12-0840
10.2337/dc08-1512
10.1111/j.1365-2265.2011.04159.x
10.2337/diabetes.54.11.3265
10.2337/db06-0319
10.1152/ajpendo.90842.2008
10.1152/ajpendo.00076.2005
10.1016/S0005-1098(96)00254-3
10.1073/pnas.0608537103
10.1056/NEJMoa054629
10.2337/diab.44.7.845
ClassificationCodes 2834
2833
ContentType Journal Article
Copyright 2015 INIST-CNRS
COPYRIGHT 2014 American Diabetes Association
COPYRIGHT 2014 American Diabetes Association
Copyright American Diabetes Association Apr 2014
2014 by the American Diabetes Association. 2014
Copyright_xml – notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2014 American Diabetes Association
– notice: COPYRIGHT 2014 American Diabetes Association
– notice: Copyright American Diabetes Association Apr 2014
– notice: 2014 by the American Diabetes Association. 2014
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
8GL
K9.
NAPCQ
7X8
5PM
DOI 10.2337/db13-1198
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: High School
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitleList ProQuest Health & Medical Complete (Alumni)

MEDLINE

CrossRef


MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1939-327X
EndPage 1213
ExternalDocumentID PMC4179313
3530572271
A363188543
24651807
28402928
10_2337_db13_1198
Genre Review
Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIDDK NIH HHS
  grantid: DK29953
– fundername: NIDDK NIH HHS
  grantid: R01 DK029953
– fundername: NCATS NIH HHS
  grantid: UL1 TR000135
– fundername: NIDDK NIH HHS
  grantid: P30 DK050456
– fundername: NIDDK NIH HHS
  grantid: R37 DK029953
GroupedDBID ---
.55
.XZ
08P
0R~
18M
29F
2WC
354
4.4
53G
5GY
5RE
5RS
5VS
6PF
8GL
8R4
8R5
AAFWJ
AAKAS
AAQQT
AAWTL
AAYEP
AAYOK
AAYXX
ABOCM
ACGFO
ACGOD
ACPRK
ADBBV
ADGHP
ADZCM
AEGXH
AENEX
AERZD
AHMBA
AIAGR
AIZAD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BES
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EDB
EJD
EMOBN
EX3
F5P
FRP
GICCO
GX1
H13
HZ~
IAG
IAO
IEA
IHR
INH
INR
IOF
IPO
ITC
K2M
KQ8
L7B
M5~
O5R
O5S
O9-
OB3
OHH
OK1
OVD
P2P
PCD
Q2X
RHI
RPM
SJN
SV3
TDI
TEORI
TR2
VVN
W8F
WH7
WOQ
WOW
X7M
YFH
YHG
YOC
ZY1
~KM
.GJ
1CY
7RV
7X7
88E
88I
8AF
8AO
8C1
8F7
8FE
8FH
8FI
8FJ
8G5
AAYJJ
ABUWG
AFFNX
AFKRA
AI.
AZQEC
BBNVY
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BKNYI
BLC
BPHCQ
BVXVI
C1A
CCPQU
DWQXO
FYUFA
GNUQQ
GUQSH
HCIFZ
HMCUK
H~9
IQODW
J5H
K-O
K9-
LK8
M0R
M1P
M2O
M2P
M2Q
M7P
MVM
N4W
NAPCQ
PEA
PHGZT
PQQKQ
PROAC
PSQYO
S0X
SJFOW
UKHRP
VH1
XOL
YQJ
ZGI
ZXP
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
5PM
ID FETCH-LOGICAL-c676t-4950f53fe3a8f637d67e820b60159d5dedb611530dcc0decacfbb7d2d6a5f33d3
ISSN 0012-1797
1939-327X
IngestDate Thu Aug 21 17:43:36 EDT 2025
Fri Jul 11 16:49:12 EDT 2025
Fri Jul 25 19:37:58 EDT 2025
Tue Jun 17 21:08:23 EDT 2025
Thu Jun 12 23:56:30 EDT 2025
Tue Jun 10 20:33:51 EDT 2025
Fri Jun 27 03:43:44 EDT 2025
Tue Jun 10 19:45:32 EDT 2025
Thu Apr 03 06:58:08 EDT 2025
Wed Apr 02 07:25:04 EDT 2025
Thu Apr 24 22:58:41 EDT 2025
Tue Jul 01 03:10:37 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Endocrinopathy
Diabetes mellitus
Models
Language English
License CC BY 4.0
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c676t-4950f53fe3a8f637d67e820b60159d5dedb611530dcc0decacfbb7d2d6a5f33d3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC4179313
PMID 24651807
PQID 1637640301
PQPubID 34443
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4179313
proquest_miscellaneous_1509411139
proquest_journals_1637640301
gale_infotracmisc_A363188543
gale_infotracgeneralonefile_A363188543
gale_infotracacademiconefile_A363188543
gale_incontextgauss_8GL_A363188543
gale_incontextcollege_GICCO_A363188543
pubmed_primary_24651807
pascalfrancis_primary_28402928
crossref_citationtrail_10_2337_db13_1198
crossref_primary_10_2337_db13_1198
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-04-01
PublicationDateYYYYMMDD 2014-04-01
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Alexandria, VA
PublicationPlace_xml – name: Alexandria, VA
– name: United States
– name: New York
PublicationTitle Diabetes (New York, N.Y.)
PublicationTitleAlternate Diabetes
PublicationYear 2014
Publisher American Diabetes Association
Publisher_xml – name: American Diabetes Association
References Cali (2022031210482469400_B38) 2009; 32
Dalla Man (2022031210482469400_B7) 2005; 289
Sathananthan (2022031210482469400_B2) 2012; 76
Breda (2022031210482469400_B20) 2001; 50
Cobelli (2022031210482469400_B13) 1999; 277
Bock (2022031210482469400_B41) 2007; 56
Dalla Man (2022031210482469400_B15) 2004; 287
Hinshaw (2022031210482469400_B44) 2013; 62
Toffolo (2022031210482469400_B11) 2006; 290
Dalla Man (2022031210482469400_B34) 2013
Bergman (2022031210482469400_B5) 1979; 236
Mari (2022031210482469400_B25) 2002; 283
Basu (2022031210482469400_B42) 2009; 32
Pillonetto (2022031210482469400_B18) 2006
Dalla Man (2022031210482469400_B14) 2002; 49
Van Cauter (2022031210482469400_B21) 1992; 41
Smushkin (2022031210482469400_B47) 2013; 62
Cobelli (2022031210482469400_B9) 2007; 293
Dalla Man (2022031210482469400_B12) 2005; 54
Bock (2022031210482469400_B40) 2006; 55
De Nicolao (2022031210482469400_B32) 1997; 33
Dalla Man (2022031210482469400_B33) 2008; 295
Pedersen (2022031210482469400_B22) 2010; 298
Basu (2022031210482469400_B8) 2006; 55
Dalla Man (2022031210482469400_B16) 2005; 289
Sunehag (2022031210482469400_B37) 2009; 17
Bock (2022031210482469400_B46) 2010; 73
Caumo (2022031210482469400_B6) 1999; 276
Campioni (2022031210482469400_B27) 2007; 292
Pedersen (2022031210482469400_B23) 2008; 366
Denti (2022031210482469400_B29) 2012; 303
Chandler-Laney (2022031210482469400_B39) 2010; 18
Hodson (2022031210482469400_B45) 2013; 45
Nair (2022031210482469400_B35) 2006; 355
Toffolo (2022031210482469400_B10) 1995; 44
Basu (2022031210482469400_B24) 2012; 61
Dalla Man (2022031210482469400_B30) 2010; 298
Bock (2022031210482469400_B17) 2007; 56
Pisprasert (2022031210482469400_B3) 2013; 36
Dalla Man (2022031210482469400_B1) 2009; 32
Saad (2022031210482469400_B43) 2012; 61
Steil (2022031210482469400_B26) 2004; 53
Petersen (2022031210482469400_B36) 2006; 103
Bergman (2022031210482469400_B28) 1981; 68
Reaven (2022031210482469400_B4) 2013
Campioni (2022031210482469400_B31) 2009; 297
Pillonetto (2022031210482469400_B19) 2010; 298
20300083 - Obesity (Silver Spring). 2010 Nov;18(11):2086-92
23223406 - Diabetes Care. 2013 Apr;36(4):845-53
12002173 - IEEE Trans Biomed Eng. 2002 May;49(5):419-29
18931099 - Diabetes Care. 2009 Jan;32(1):14-8
15111487 - Diabetes. 2004 May;53(5):1201-7
17050889 - N Engl J Med. 2006 Oct 19;355(16):1647-59
23443923 - Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E819-25
16868229 - Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E54-60
20039889 - Clin Endocrinol (Oxf). 2010 Aug;73(2):189-96
21707690 - Clin Endocrinol (Oxf). 2012 Feb;76(2):212-9
17130502 - Diabetes. 2006 Dec;55(12):3536-49
11147781 - Diabetes. 2001 Jan;50(1):150-8
20179243 - Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1115-21
19196896 - Diabetes Care. 2009 May;32(5):866-72
15138152 - Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E637-43
443421 - Am J Physiol. 1979 Jun;236(6):E667-77
17384334 - Diabetes. 2007 Jun;56(6):1703-11
12388151 - Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66
19106382 - Diabetes Care. 2009 Mar;32(3):456-61
22751690 - Diabetes. 2012 Nov;61(11):2691-700
10362630 - Am J Physiol. 1999 Jun;276(6 Pt 1):E1171-93
16804069 - Diabetes. 2006 Jul;55(7):2001-14
23722624 - Diabetologia. 2013 Aug;56(8):1867-8
19920215 - Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E440-8
17114290 - Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18273-7
10484360 - Am J Physiol. 1999 Sep;277(3 Pt 1):E481-8
18765681 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1152-9
22669244 - Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E576-86
15972269 - Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E909-14
16144811 - Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E169-E176
17341552 - Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E1-E15
16532763 - IEEE Trans Biomed Eng. 2006 Mar;53(3):369-79
22275083 - Diabetes. 2012 Feb;61(2):270-1
19671837 - Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E941-8
16249454 - Diabetes. 2005 Nov;54(11):3265-73
23447123 - Diabetes. 2013 Jul;62(7):2223-9
23250357 - Diabetes. 2013 Apr;62(4):1094-101
24651802 - Diabetes. 2014 Apr;63(4):1188-90
17395750 - Diabetes. 2007 Apr;56(4):1113-9
19057529 - Obesity (Silver Spring). 2009 Feb;17(2):233-9
23549674 - Horm Metab Res. 2013 Aug;45(8):567-71
1551497 - Diabetes. 1992 Mar;41(3):368-77
20009025 - Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E597-601
7789653 - Diabetes. 1995 Jul;44(7):845-54
18653438 - Philos Trans A Math Phys Eng Sci. 2008 Oct 13;366(1880):3525-43
7033284 - J Clin Invest. 1981 Dec;68(6):1456-67
16014353 - Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E954-9
References_xml – volume: 56
  start-page: 1113
  year: 2007
  ident: 2022031210482469400_B17
  article-title: Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes
  publication-title: Diabetes
  doi: 10.2337/db06-1272
– volume: 298
  start-page: E1115
  year: 2010
  ident: 2022031210482469400_B30
  article-title: A model of GLP-1 action on insulin secretion in nondiabetic subjects
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00705.2009
– volume: 295
  start-page: E1152
  year: 2008
  ident: 2022031210482469400_B33
  article-title: Use of labeled oral minimal model to measure hepatic insulin sensitivity
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00486.2007
– volume: 277
  start-page: E481
  year: 1999
  ident: 2022031210482469400_B13
  article-title: Minimal model SG overestimation and SI underestimation: improved accuracy by a Bayesian two-compartment model
  publication-title: Am J Physiol
– volume: 287
  start-page: E637
  year: 2004
  ident: 2022031210482469400_B15
  article-title: Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00319.2003
– volume: 62
  start-page: 1094
  year: 2013
  ident: 2022031210482469400_B47
  article-title: The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/db12-0923
– volume: 55
  start-page: 2001
  year: 2006
  ident: 2022031210482469400_B8
  article-title: Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction
  publication-title: Diabetes
  doi: 10.2337/db05-1692
– volume: 292
  start-page: E54
  year: 2007
  ident: 2022031210482469400_B27
  article-title: Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00033.2006
– volume: 303
  start-page: E576
  year: 2012
  ident: 2022031210482469400_B29
  article-title: The disposition index: from individual to population approach
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00139.2011
– start-page: E819
  volume-title: Am J Physiol Endocrinol Metab
  year: 2013
  ident: 2022031210482469400_B34
  article-title: Modeling hepatic insulin sensitivity during a meal: validation against the euglycemic-hyperinsulinemic clamp
– volume: 366
  start-page: 3525
  year: 2008
  ident: 2022031210482469400_B23
  article-title: A subcellular model of glucose-stimulated pancreatic insulin secretion
  publication-title: Philos Trans A Math Phys Eng Sci
– volume: 53
  start-page: 1201
  year: 2004
  ident: 2022031210482469400_B26
  article-title: Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test
  publication-title: Diabetes
  doi: 10.2337/diabetes.53.5.1201
– volume: 289
  start-page: E909
  year: 2005
  ident: 2022031210482469400_B7
  article-title: Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00299.2004
– volume: 18
  start-page: 2086
  year: 2010
  ident: 2022031210482469400_B39
  article-title: Adiposity and β-cell function: relationships differ with ethnicity and age
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2010.44
– volume: 68
  start-page: 1456
  year: 1981
  ident: 2022031210482469400_B28
  article-title: Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose
  publication-title: J Clin Invest
  doi: 10.1172/JCI110398
– volume: 61
  start-page: 2691
  year: 2012
  ident: 2022031210482469400_B43
  article-title: Diurnal pattern to insulin secretion and insulin action in healthy individuals
  publication-title: Diabetes
  doi: 10.2337/db11-1478
– volume: 62
  start-page: 2223
  year: 2013
  ident: 2022031210482469400_B44
  article-title: Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system
  publication-title: Diabetes
  doi: 10.2337/db12-1759
– volume: 45
  start-page: 567
  year: 2013
  ident: 2022031210482469400_B45
  article-title: Mechanism of insulin resistance in normal pregnancy
  publication-title: Horm Metab Res
  doi: 10.1055/s-0033-1337988
– volume: 276
  start-page: E1171
  year: 1999
  ident: 2022031210482469400_B6
  article-title: Undermodeling affects minimal model indexes: insights from a two-compartment model
  publication-title: Am J Physiol
– volume: 49
  start-page: 419
  year: 2002
  ident: 2022031210482469400_B14
  article-title: The oral glucose minimal model: estimation of insulin sensitivity from a meal test
  publication-title: IEEE Trans Biomed Eng
  doi: 10.1109/10.995680
– volume: 17
  start-page: 233
  year: 2009
  ident: 2022031210482469400_B37
  article-title: beta-Cell function and insulin sensitivity in adolescents from an OGTT
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2008.496
– volume: 56
  start-page: 1703
  year: 2007
  ident: 2022031210482469400_B41
  article-title: Contribution of hepatic and extrahepatic insulin resistance to the pathogenesis of impaired fasting glucose: role of increased rates of gluconeogenesis
  publication-title: Diabetes
  doi: 10.2337/db06-1776
– volume: 290
  start-page: E169
  year: 2006
  ident: 2022031210482469400_B11
  article-title: A minimal model of insulin secretion and kinetics to assess hepatic insulin extraction
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00473.2004
– volume: 73
  start-page: 189
  year: 2010
  ident: 2022031210482469400_B46
  article-title: The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2009.03764.x
– volume: 61
  start-page: 270
  year: 2012
  ident: 2022031210482469400_B24
  article-title: Prediabetes: evaluation of β-cell function
  publication-title: Diabetes
  doi: 10.2337/db11-1677
– volume: 293
  start-page: E1
  year: 2007
  ident: 2022031210482469400_B9
  article-title: Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00421.2006
– start-page: 369
  volume-title: IEEE Trans Biomed Eng
  year: 2006
  ident: 2022031210482469400_B18
  article-title: A new dynamic index of insulin sensitivity
– volume: 283
  start-page: E1159
  year: 2002
  ident: 2022031210482469400_B25
  article-title: Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00093.2002
– volume: 32
  start-page: 866
  year: 2009
  ident: 2022031210482469400_B42
  article-title: Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1826
– volume: 298
  start-page: E440
  year: 2010
  ident: 2022031210482469400_B19
  article-title: Dynamic insulin sensitivity index: importance in diabetes
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.90340.2008
– volume: 50
  start-page: 150
  year: 2001
  ident: 2022031210482469400_B20
  article-title: Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity
  publication-title: Diabetes
  doi: 10.2337/diabetes.50.1.150
– volume: 41
  start-page: 368
  year: 1992
  ident: 2022031210482469400_B21
  article-title: Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance
  publication-title: Diabetes
  doi: 10.2337/diabetes.41.3.368
– volume: 298
  start-page: E597
  year: 2010
  ident: 2022031210482469400_B22
  article-title: Cellular modeling: insight into oral minimal models of insulin secretion
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00670.2009
– volume: 32
  start-page: 456
  year: 2009
  ident: 2022031210482469400_B38
  article-title: Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1274
– volume: 36
  start-page: 845
  year: 2013
  ident: 2022031210482469400_B3
  article-title: Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans
  publication-title: Diabetes Care
  doi: 10.2337/dc12-0840
– volume: 32
  start-page: 14
  year: 2009
  ident: 2022031210482469400_B1
  article-title: Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes
  publication-title: Diabetes Care
  doi: 10.2337/dc08-1512
– volume: 76
  start-page: 212
  year: 2012
  ident: 2022031210482469400_B2
  article-title: A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations
  publication-title: Clin Endocrinol (Oxf)
  doi: 10.1111/j.1365-2265.2011.04159.x
– volume: 54
  start-page: 3265
  year: 2005
  ident: 2022031210482469400_B12
  article-title: Two-hour seven-sample oral glucose tolerance test and meal protocol: minimal model assessment of beta-cell responsivity and insulin sensitivity in nondiabetic individuals
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.11.3265
– volume: 55
  start-page: 3536
  year: 2006
  ident: 2022031210482469400_B40
  article-title: Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance
  publication-title: Diabetes
  doi: 10.2337/db06-0319
– volume: 297
  start-page: E941
  year: 2009
  ident: 2022031210482469400_B31
  article-title: Minimal model assessment of hepatic insulin extraction during an oral test from standard insulin kinetic parameters
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.90842.2008
– volume: 289
  start-page: E954
  year: 2005
  ident: 2022031210482469400_B16
  article-title: Insulin sensitivity by oral glucose minimal models: validation against clamp
  publication-title: Am J Physiol Endocrinol Metab
  doi: 10.1152/ajpendo.00076.2005
– volume: 33
  start-page: 851
  year: 1997
  ident: 2022031210482469400_B32
  article-title: Nonparametric input estimation in physiological systems: problems, methods, case studies
  publication-title: Automatica
  doi: 10.1016/S0005-1098(96)00254-3
– volume: 103
  start-page: 18273
  year: 2006
  ident: 2022031210482469400_B36
  article-title: Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0608537103
– volume: 236
  start-page: E667
  year: 1979
  ident: 2022031210482469400_B5
  article-title: Quantitative estimation of insulin sensitivity
  publication-title: Am J Physiol
– volume: 355
  start-page: 1647
  year: 2006
  ident: 2022031210482469400_B35
  article-title: DHEA in elderly women and DHEA or testosterone in elderly men
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa054629
– start-page: 1867
  volume-title: Diabetologia
  year: 2013
  ident: 2022031210482469400_B4
  article-title: What do we learn from measurements of HOMA-IR?
– volume: 44
  start-page: 845
  year: 1995
  ident: 2022031210482469400_B10
  article-title: Estimation of beta-cell sensitivity from intravenous glucose tolerance test C-peptide data. Knowledge of the kinetics avoids errors in modeling the secretion
  publication-title: Diabetes
  doi: 10.2337/diab.44.7.845
– reference: 17341552 - Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E1-E15
– reference: 10362630 - Am J Physiol. 1999 Jun;276(6 Pt 1):E1171-93
– reference: 1551497 - Diabetes. 1992 Mar;41(3):368-77
– reference: 23722624 - Diabetologia. 2013 Aug;56(8):1867-8
– reference: 22275083 - Diabetes. 2012 Feb;61(2):270-1
– reference: 23250357 - Diabetes. 2013 Apr;62(4):1094-101
– reference: 15138152 - Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E637-43
– reference: 23223406 - Diabetes Care. 2013 Apr;36(4):845-53
– reference: 21707690 - Clin Endocrinol (Oxf). 2012 Feb;76(2):212-9
– reference: 17050889 - N Engl J Med. 2006 Oct 19;355(16):1647-59
– reference: 19106382 - Diabetes Care. 2009 Mar;32(3):456-61
– reference: 15111487 - Diabetes. 2004 May;53(5):1201-7
– reference: 20039889 - Clin Endocrinol (Oxf). 2010 Aug;73(2):189-96
– reference: 23447123 - Diabetes. 2013 Jul;62(7):2223-9
– reference: 17384334 - Diabetes. 2007 Jun;56(6):1703-11
– reference: 18765681 - Am J Physiol Endocrinol Metab. 2008 Nov;295(5):E1152-9
– reference: 16868229 - Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E54-60
– reference: 7789653 - Diabetes. 1995 Jul;44(7):845-54
– reference: 19057529 - Obesity (Silver Spring). 2009 Feb;17(2):233-9
– reference: 20179243 - Am J Physiol Endocrinol Metab. 2010 Jun;298(6):E1115-21
– reference: 16144811 - Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E169-E176
– reference: 19196896 - Diabetes Care. 2009 May;32(5):866-72
– reference: 12388151 - Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66
– reference: 11147781 - Diabetes. 2001 Jan;50(1):150-8
– reference: 10484360 - Am J Physiol. 1999 Sep;277(3 Pt 1):E481-8
– reference: 16532763 - IEEE Trans Biomed Eng. 2006 Mar;53(3):369-79
– reference: 17395750 - Diabetes. 2007 Apr;56(4):1113-9
– reference: 17130502 - Diabetes. 2006 Dec;55(12):3536-49
– reference: 20009025 - Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E597-601
– reference: 19671837 - Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E941-8
– reference: 17114290 - Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18273-7
– reference: 7033284 - J Clin Invest. 1981 Dec;68(6):1456-67
– reference: 20300083 - Obesity (Silver Spring). 2010 Nov;18(11):2086-92
– reference: 443421 - Am J Physiol. 1979 Jun;236(6):E667-77
– reference: 16249454 - Diabetes. 2005 Nov;54(11):3265-73
– reference: 16804069 - Diabetes. 2006 Jul;55(7):2001-14
– reference: 24651802 - Diabetes. 2014 Apr;63(4):1188-90
– reference: 23443923 - Am J Physiol Endocrinol Metab. 2013 Apr 15;304(8):E819-25
– reference: 16014353 - Am J Physiol Endocrinol Metab. 2005 Dec;289(6):E954-9
– reference: 12002173 - IEEE Trans Biomed Eng. 2002 May;49(5):419-29
– reference: 19920215 - Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E440-8
– reference: 18931099 - Diabetes Care. 2009 Jan;32(1):14-8
– reference: 23549674 - Horm Metab Res. 2013 Aug;45(8):567-71
– reference: 18653438 - Philos Trans A Math Phys Eng Sci. 2008 Oct 13;366(1880):3525-43
– reference: 15972269 - Am J Physiol Endocrinol Metab. 2005 Nov;289(5):E909-14
– reference: 22669244 - Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E576-86
– reference: 22751690 - Diabetes. 2012 Nov;61(11):2691-700
SSID ssj0006060
Score 2.5190067
SecondaryResourceType review_article
Snippet The simultaneous assessment of insulin action, secretion, and hepatic extraction is key to understanding postprandial glucose metabolism in nondiabetic and...
SourceID pubmedcentral
proquest
gale
pubmed
pascalfrancis
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1203
SubjectTerms Adolescent
Biological and medical sciences
Blood Glucose - metabolism
C-Peptide - metabolism
Child
Diabetes
Diabetes. Impaired glucose tolerance
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Food
Glucose
Glucose - metabolism
Glucose Clamp Technique
Glucose Tolerance Test
Human subjects
Humans
Insulin
Insulin - metabolism
Insulin - physiology
Insulin Resistance - physiology
Insulin-Secreting Cells - drug effects
Insulin-Secreting Cells - physiology
Liver - metabolism
Mathematical models
Medical sciences
Metabolism
Methodology Review
Models, Biological
Pancreatic beta cells
Physiology
Postprandial Period - physiology
Testing
Title The Oral Minimal Model Method
URI https://www.ncbi.nlm.nih.gov/pubmed/24651807
https://www.proquest.com/docview/1637640301
https://www.proquest.com/docview/1509411139
https://pubmed.ncbi.nlm.nih.gov/PMC4179313
Volume 63
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6hIiEkhHgTSCuDUEFCBnvXXtvHKkArRCiHVMrN2meJ1NpRk1z49cx4N35EOUAvSWRP1t6dz7Mz43kQ8k7rNJJW5iHPhQ0TinLQGhpKZUF7ZZrmArORpz_52UXyfZ7OO2dOk12ylp_Un715JbfhKhwDvmKW7H9wth0UDsBv4C98Aofh8595fI4Z9tNFtbjGb-xr83HadIXuq51feh7W3d47PV_ApMbXEM37_cmV2GgXo-Uc2QAXjJVxr-gX4qYV57Pa2tq9wDkFrFWdhS9WG5e7vxZ950Lcj0np4vlB0LS3uQsaL1ZjinVO3c5pnCQtWBEyms37otbLskXfj9DIzZhGrLcHY525ffKdsqZCgJYxC-PYta_u8Xl53TCaYn_3PMq6La4NPPw1nWDLNYZ9ju9SsCzY1sHjN2-w51zWkp-RK0aF1_3cXhULSPtLDLQZv6c_WIoVPF_WNUbZZ7nsBuD2NJrZI_LQmyLBicPVY3LHVE_IvakPtnhKDgFeAcIr8PAKGngFDl7PyMW3r7PJWei7aYSKZ3wdgiUc2ZRZw0RuOcs0zwyofxIs8rTQqTZacjAPWKSVirRRQlkpM001F6llTLPn5KCqK_OSBKnimjIVFSaRiZCJbArfcclFxgsp6Yh82K5KqXypeex4clWCyYlrWeJalriWI_K2JV26-ir7iI5xaUusV1JhQJRyTrUS5jc5L08Yh50pTxMGow0JL8VmtSrz0x8DoveeyNZwVzBRl4gCc8NaaAPK4wHlpasEv49wPCAEEa0Gp48GmGhnCrphRAsKExxvQVJ6-bIqwVLKeIIuixF5057GoTEusjL1Bmiw_iWoK6wYkRcOU93gHqMjkg3Q1hJgZfnhmWrxu6kw75-RV7f-52tyvxMnY3KwvtmYQ9De1_Koed7-ApJ56oc
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Oral+Minimal+Model+Method&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Cobelli%2C+Claudio&rft.au=Dalla+Man%2C+Chiara&rft.au=Toffolo%2C+Gianna&rft.au=Basu%2C+Rita&rft.date=2014-04-01&rft.pub=American+Diabetes+Association&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=63&rft.issue=4&rft.spage=1203&rft.epage=1213&rft_id=info:doi/10.2337%2Fdb13-1198&rft_id=info%3Apmid%2F24651807&rft.externalDocID=PMC4179313
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon